Use of antithrombotic therapy and long-term clinical outcome among patients surviving intracerebral hemorrhage

Stroke

Volumn 47, Issue 7, 2016, Pages 1837-1843

  Ottosen, Tobias Pilgaard ^a   Grijota, Miriam ^a   Hansen, Morten Lock ^b   Brandes, Axel ^c   Damgaard, Dorte ^a   Husted, Steen Elkjær ^d   Johnsen, Søren Paaske ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d REGIONAL HOSPITAL WEST JUTLAND   (Denmark)

Author keywords

anticoagulants; atrial fibrillation; epidemiology; intracerebral hemorrhage; stroke

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; COHORT ANALYSIS; DRUG INDICATION; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE ASSESSMENT; OUTCOME ASSESSMENT; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; SCANDINAVIAN STROKE SCALE; SMOKING; THROMBOEMBOLISM; CAUSE OF DEATH; CEREBRAL HEMORRHAGE; CHEMICALLY INDUCED; DENMARK; FOLLOW UP; HEMORRHAGE; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; RECURRENT DISEASE; STATISTICS AND NUMERICAL DATA; SURVIVOR; THROMBOPHILIA; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CEREBRAL HEMORRHAGE; DENMARK; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MORTALITY; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; RECURRENCE; SURVIVORS; THROMBOEMBOLISM; THROMBOPHILIA; TREATMENT OUTCOME;

EID: 84974855178     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.116.012945     Document Type: Article

References (23)

1. Eckman MH, Rosand J, Knudsen KA, Singer DE, Greenberg SM, Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke 2003 34 1710 1716. doi: 10.1161/01.STR.0000078311.18928.16.
2. Pennlert J, Asplund K, Carlberg B, Wiklund PG, Wisten A, Åsberg S, Antithrombotic treatment following intracerebral hemorrhage in patients with and without atrial fibrillation. Stroke 2015 46 2094 2099. doi: 10.1161/STROKEAHA.115.009087.
3. Pasquini M, Charidimou A, van Asch CJ, Baharoglu MI, Samarasekera N, Werring DJ, Variation in restarting antithrombotic drugs at hospital discharge after intracerebral hemorrhage. Stroke 2014 45 2643 2648. doi: 10.1161/STROKEAHA.114.006202.
4. Kuramatsu JB, Gerner ST, Schellinger PD, Glahn J, Endres M, Sobesky J, Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. JAMA 2015 313 824 836. doi: 10.1001/jama.2015.0846.
5. Albrecht JS, Liu X, Baumgarten M, Langenberg P, Rattinger GB, Smith GS, Benefits and risks of anticoagulation resumption following traumatic brain injury. JAMA Intern Med 2014 174 1244 1251. doi: 10.1001/jamainternmed.2014.2534.
6. Nielsen PB, Larsen TB, Skjøth F, Gorst-Rasmussen A, Rasmussen LH, Lip GY, Restarting anticoagulant treatment after intracranial hemorrhage in patients with atrial fibrillation and the impact on recurrent stroke, mortality, and bleeding: A nationwide cohort study. Circulation 2015 132 517 525. doi: 10.1161/CIRCULATIONAHA.115.015735.
7. Chao TF, Liu CJ, Liao JN, Wang KL, Lin YJ, Chang SL, Use of oral anticoagulants for stroke prevention in patients with atrial fibrillation who have a history of intracranial hemorrhage. Circulation 2016 133 1540 1547. doi: 10.1161/CIRCULATIONAHA.115.019794.
8. Mainz J, Krog BR, Bjørnshave B, Bartels P, Nationwide continuous quality improvement using clinical indicators: the Danish National Indicator Project. Int J Qual Health Care 2004 16 suppl 1 i45 i50. doi: 10.1093/intqhc/mzh031.
9. Wildenschild C, Mehnert F, Thomsen RW, Iversen HK, Vestergaard K, Ingeman A, Registration of acute stroke: validity in the Danish Stroke Registry and the Danish National Registry of Patients. Clin Epidemiol 2014 6 27 36. doi: 10.2147/CLEP.S50449.
10. Schmidt M, Pedersen L, Sørensen HT, The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol 2014 29 541 549. doi: 10.1007/s10654-014-9930-3.
11. Bailey RD, Hart RG, Benavente O, Pearce LA, Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage. Neurology 2001 56 773 777
12. Majeed A, Kim YK, Roberts RS, Holmström M, Schulman S, Optimal timing of resumption of warfarin after intracranial hemorrhage. Stroke 2010 41 2860 2866. doi: 10.1161/STROKEAHA.110.593087.
13. Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT, The Danish National Patient Registry: A review of content, data quality, and research potential. Clin Epidemiol 2015 7 449 490. doi: 10.2147/CLEP.S91125.
14. Schmidt M, Hallas J, Friis S, Potential of prescription registries to capture individual-level use of aspirin and other nonsteroidal anti-inflammatory drugs in Denmark: trends in utilization 1999-2012. Clin Epidemiol 2014 6 155 168. doi: 10.2147/CLEP.S59156.
15. ATC/DDD Index 2015. WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atc-ddd-index/. Accessed July 22, 2015.
16. Charlson ME, Pompei P, Ales KL, MacKenzie CR, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987 40 373 383
17. Multicenter trial of hemodilution in ischemic stroke-background and study protocol Scandinavian Stroke Study Group. Stroke 1985 16 885 890
18. Olesen JB, Lip GY, Hansen ML, Hansen PR, Tolstrup JS, Lindhardsen J, Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ 2011 342 d124
19. Olesen JB, Lip GY, Hansen PR, Lindhardsen J, Ahlehoff O, Andersson C, Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort. J Thromb Haemost 2011 9 1460 1467. doi: 10.1111/j.1538-7836.2011.04378.x.
20. Flynn RW, MacDonald TM, Murray GD, MacWalter RS, Doney AS, Prescribing antiplatelet medicine and subsequent events after intracerebral hemorrhage. Stroke 2010 41 2606 2611. doi: 10.1161/STROKEAHA.110.589143.
21. Passero S, Burgalassi L, D'Andrea P, Battistini N, Recurrence of bleeding in patients with primary intracerebral hemorrhage. Stroke 1995 26 1189 1192
22. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G, Volume of intracerebral hemorrhage. A powerful and easy-To-use predictor of 30-day mortality. Stroke 1993 24 987 993
23. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Standardized bleeding definitions for cardiovascular clinical trials: A consensus report from the Bleeding Academic Research Consortium. Circulation 2011 123 2736 2747. doi: 10.1161/CIRCULATIONAHA.110.009449.